Navid Dastyafteh

403 total citations
35 papers, 272 citations indexed

About

Navid Dastyafteh is a scholar working on Organic Chemistry, Computational Theory and Mathematics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Navid Dastyafteh has authored 35 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 11 papers in Computational Theory and Mathematics and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Navid Dastyafteh's work include Synthesis and biological activity (16 papers), Computational Drug Discovery Methods (11 papers) and Natural Antidiabetic Agents Studies (11 papers). Navid Dastyafteh is often cited by papers focused on Synthesis and biological activity (16 papers), Computational Drug Discovery Methods (11 papers) and Natural Antidiabetic Agents Studies (11 papers). Navid Dastyafteh collaborates with scholars based in Iran, Türkiye and Sweden. Navid Dastyafteh's co-authors include Mohammad Mahdavi, Milad Noori, Bagher Larijani, Aida Iraji, Mohammad Ali Faramarzi, Somayeh Mojtabavi, Shahrzad Javanshir, Mohammad Nazari Montazer, Mehdi Asadi and Cambyz Irajie and has published in prestigious journals such as Scientific Reports, RSC Advances and International Journal of Biological Macromolecules.

In The Last Decade

Navid Dastyafteh

30 papers receiving 267 citations

Peers

Countries citing papers authored by Navid Dastyafteh

Since Specialization

Citations

This map shows the geographic impact of Navid Dastyafteh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navid Dastyafteh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navid Dastyafteh more than expected).

Fields of papers citing papers by Navid Dastyafteh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Navid Dastyafteh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navid Dastyafteh. The network helps show where Navid Dastyafteh may publish in the future.

Co-authorship network of co-authors of Navid Dastyafteh

This figure shows the co-authorship network connecting the top 25 collaborators of Navid Dastyafteh. A scholar is included among the top collaborators of Navid Dastyafteh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navid Dastyafteh. Navid Dastyafteh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New benzothiazole-indole-1,2,3-triazole-N-phenylacetamide derivatives as cytotoxic agents: Design, synthesis, and in vitro cytotoxic evaluations 2025 ·Journal of Molecular Structure ·(unknown), Mohammad Hosein Sayahi, (unknown), Navid Dastyafteh, Maryam Mohammadi‐Khanaposhtani, (unknown), (unknown), (unknown), (unknown), Bagher Larijani, Mohammad Mahdavi, Omidreza Firuzi	2
2	Cinnamic acid conjugated with triazole acetamides as anti-Alzheimer and anti-melanogenesis candidates: an in vitro and in silico study 2025 ·Scientific Reports ·(unknown), Mohammad Hosein Sayahi, Mohammad Hashem Hashempur, Cambyz Irajie, (unknown), (unknown), Milad Noori, Navid Dastyafteh, Javad Mottaghipisheh, Mehdi Asadi, Bagher Larijani, Mohammad Mahdavi, Aida Iraji	4
3	Synthesis, biological evaluation, and docking analysis of novel benzimidazole–triazole hybrids as potential anticancer agents 2025 ·RSC Advances ·(unknown), Sara Ranjbar, Mohammad Hosein Sayahi, Zahra Dehghani, (unknown), Manica Negahdaripour, Navid Dastyafteh, (unknown), (unknown), (unknown), Mohammad Reza Mohajeri‐Tehrani, Bagher Larijani, (unknown), Younes Ghasemi	0
4	Novel diazen-bis(phenoxy-1,2,3-triazole-N-phenylacetamide) derivatives as potent anti-cholinesterase, anti-α-glycosidase and anti-α-amylase agents: In vitro and in silico evaluations 2025 ·Journal of Molecular Structure ·(unknown), Maryam Mohammadi‐Khanaposhtani, (unknown), Navid Dastyafteh, (unknown), (unknown), Bagher Larijani, (unknown), Aydın Aktaş, Nastaran Sadeghian, Parham Taslımı, (unknown), İlhami Gülçın	1
5	Development of mercapto-phenyl-1,2,4-triazole bearing thio-quinoline as a novel class of tyrosinase inhibitors: an in vitro and in silico study 2025 ·Scientific Reports ·(unknown), Mohammad Hosein Sayahi, Najmeh Oliyaei, Milad Noori, Navid Dastyafteh, Mohammad Mahdavi, Bagher Larijani, Parviz Rashidi Ranjbar, Aida Iraji	1
6	Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure–activity relationship studies 2024 ·Scientific Reports ·Haleh Hamedifar, (unknown), (unknown), Homa Azizian, Aida Iraji, Milad Noori, Ali Moazzam, Navid Dastyafteh, (unknown), (unknown), Shahrzad Javanshir, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Bagher Larijani, (unknown), Mohammad Mahdavi	7
7	Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties 2024 ·European Journal of Medicinal Chemistry ·(unknown), Milad Noori, (unknown), Aida Iraji, (unknown), Navid Dastyafteh, (unknown), Mahdi Gholami, Shahrzad Javanshir, (unknown), Somayeh Mojtabavi, Mohammad Ali Faramarzi, Mehdi Asadi, Ensieh Nasli‐Esfahani, (unknown), Bagher Larijani, Mohammad Hadi Meshkatalsadat, Mohammad Mahdavi	13
8	New benzimidazole–indole–amide derivatives as potent α‐glucosidase and acetylcholinesterase inhibitors 2024 ·Archiv der Pharmazie ·(unknown), (unknown), Navid Dastyafteh, (unknown), Maryam Mohammadi‐Khanaposhtani, (unknown), Bagher Larijani, (unknown), İlhami Çelik, Aydın Aktaş, (unknown), (unknown), Mohammad Mahdavi	3
9	Design, synthesis, and cytotoxic activity of 2-amino-1,4-naphthoquinone-benzamide derivatives as apoptosis inducers 2024 ·Scientific Reports ·Mohammad Hosein Sayahi, (unknown), Maryam Mohammadi‐Khanaposhtani, Navid Dastyafteh, Mahmood Reza Gohari, (unknown), Bagher Larijani, Mohammad Mahdavi, (unknown)	4
10	Design of new α-glucosidase inhibitors based on the bis-4-hydroxycoumarin skeleton: Synthesis, evaluation, and in silico studies 2024 ·Scientific Reports ·Zahra Soleimani, Mohammad Hossein Mohammadi, (unknown), (unknown), Navid Dastyafteh, (unknown), Somayeh Mojtabavi, Mohammad Ali Faramarzi, (unknown), Bagher Larijani, Maryam Mohammadi‐Khanaposhtani, Mohammad Mahdavi	0
11	Design of novel benzimidazole-propane hydrazide derivatives as α-glucosidase and α-amylase inhibitors: in vitro and in silico studies 2024 ·Medicinal Chemistry Research ·(unknown), (unknown), Navid Dastyafteh, Milad Noori, (unknown), Maryam Mohammadi‐Khanaposhtani, Bagher Larijani, Mohammad Mahdavi, (unknown), Aydın Aktaş, Parham Taslımı, İlhami Gülçın	2
12	α-Glucosidase inhibition assay of galbanic acid and it amide derivatives: New excellent semi-synthetic α-glucosidase inhibitors 2024 ·Bioorganic Chemistry ·Maryam Mohammadi‐Khanaposhtani, Mohammad Hosein Sayahi, (unknown), Navid Dastyafteh, (unknown), Aida Iraji, (unknown), Somayeh Mojtabavi, Mohammad Ali Faramarzi, (unknown), (unknown), Bagher Larijani, Mohammad‐Reza Delnavazi, Mohammad Mahdavi	4
13	Isoindolinedione-Benzamide Pyridinium Derivatives for Targeting Alzheimer’s Disease 2024 ·ACS Omega ·Milad Noori, (unknown), Navid Dastyafteh, Najmeh Oliyaei, Haleh Hamedifar, Shahrzad Javanshir, Nader Tanideh, (unknown), (unknown), M Haghani, (unknown), Bagher Larijani, Mohammad Mahdavi, (unknown), Aida Iraji	1
14	Thioquinoline derivatives conjugated to thiosemicarbazide as potent tyrosinase inhibitors with anti-melanogenesis properties 2023 ·Scientific Reports ·Milad Noori, Reyhaneh Sabourian, (unknown), Maliheh Safavi, Aida Iraji, (unknown), Navid Dastyafteh, Cambyz Irajie, Elham Zarenezhad, (unknown), (unknown), Bagher Larijani, Mohsen Amini, Mannan Hajimahmoodi, Mohammad Mahdavi	14
15	Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline–quinazolinone–thioacetamides 2023 ·RSC Advances ·(unknown), (unknown), (unknown), Milad Noori, Navid Dastyafteh, Shahrzad Javanshir, Samanesadat Hosseini, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Ensieh Nasli‐Esfahani, Bagher Larijani, (unknown), Mohammad G. Dekamin, Maryam Mohammadi‐Khanaposhtani, Mohammad Mahdavi	8
16	Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones 2023 ·BMC Chemistry ·(unknown), Milad Noori, Navid Dastyafteh, (unknown), (unknown), (unknown), (unknown), (unknown), Cambyz Irajie, (unknown), (unknown), Bagher Larijani, Aida Iraji, Mohammad Mahdavi	5
17	[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as new therapeutic candidates against urease positive microorganisms: design, synthesis, pharmacological evaluations, and in silico studies 2023 ·Scientific Reports ·(unknown), Milad Noori, Mohammad Nazari Montazer, Kamiar Zomorodian, Navid Dastyafteh, Somayeh Yazdanpanah, Mohammad Hosein Sayahi, Shahrzad Javanshir, (unknown), Mehdi Asadi, Hamid Badali, Bagher Larijani, Cambyz Irajie, Aida Iraji, Mohammad Mahdavi	19
18	Synthesis and structure–activity relationship studies of benzimidazole-thioquinoline derivatives as α-glucosidase inhibitors 2023 ·Scientific Reports ·(unknown), Milad Noori, Mohammad Nazari Montazer, (unknown), (unknown), Navid Dastyafteh, Cambyz Irajie, Kamiar Zomorodian, Seyedeh Sara Mirfazli, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Bagher Larijani, Aida Iraji, Mohammad Mahdavi	35
19	New thioxothiazolidinyl-acetamides derivatives as potent urease inhibitors: design, synthesis, in vitro inhibition, and molecular dynamic simulation 2023 ·Scientific Reports ·Navid Dastyafteh, Milad Noori, Mohammad Nazari Montazer, Kamiar Zomorodian, Somayeh Yazdanpanah, Aida Iraji, (unknown), Shahrzad Javanshir, Mehdi Asadi, Mehdi Dianatpour, Mahmood Biglar, Bagher Larijani, Massoud Amanlou, Mohammad Mahdavi	10
20	Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3β level targeting Alzheimer's disease 2023 ·International Journal of Biological Macromolecules ·Milad Noori, Navid Dastyafteh, (unknown), (unknown), (unknown), Kamiar Zomorodian, Haleh Hamedifar, Mahintaj Dara, Shahrokh Zare, Cambyz Irajie, Shahrzad Javanshir, Hossein Rastegar, (unknown), Bagher Larijani, Mohammad Mahdavi, (unknown), Aida Iraji	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact